Welcome to RAlly!
To participate in this study, you need to only identify RA patients either starting abatacept as part of their ordinary patient care or switching or starting other biologics or DMARDs, ask them to complete a simple one-page pre-enrollment form, and answer three questions about each patient’s RA. NDB will then contact the patient to finish the enrollment process and then every 6 months with a questionnaire. If you are interested in participating in RAlly or would like more information about the RAlly study please click here.
Welcome to the NDB RAlly site for physicians.
If you already have an account, please sign in below using your email address and password.
If this is your first time to the NDB RAlly site, and you are a participating physician, please register for a password by clicking here.
If you have already registered but have lost your password, please click here.